Optical Coherence Tomography of Retinal Abnormalities Associated With Choroidal Nevus, Choroidal Melanoma and Choroidal Melanoma Treated With Iodine-125 Brachytherapy
Stopped early
Conditions studied: Ocular Melanoma
In brief
During regularly scheduled appointments, Optical Coherence Tomography (OCT) is performed on consented subjects. The OCT is a new type of camera that takes very detailed pictures inside of the eye and deeper into eye tissues. Optical Coherence Tomography imaging of intraocular tumors may lead to improved diagnosis and monitoring of tumors within the eye.
Key facts
- Study ID
- NCT00346372
- Run by
- Jonsson Comprehensive Cancer Center
- People needed
- 5
- Starts
- 2004-03-01
- Expected to finish
- 2017-11-27
- Last updated by the study team
- 2019-08-12
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adults (18 years or older) with:
- choroidal nevus greater than or equal to 3.0 mm in longest basal diameter, or greater than or equal to 1.25 mm in apical height or:
- choroidal melanoma located in the posterior pole (4mm or less from the center of fovea or the border of the optic nerve head)
You may not qualify if…
- Ocular media opacity in the tumor eye that prevents adequate functional testing or imaging and prior or concurrent retinal or choroidal disease in the tumor eye that prevents adequate functional testing or imaging
Where it is running
- Jules Stein Eye Institute — Los Angeles, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.